Scientists from Yale University have found a way to cause an effective immune response to “complex” cancer tumors using Lupus -related antibodies....
Vous n'êtes pas connecté
In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of therapy involves labeling the CD20 protein on the surface of the B cells with customised antibodies. This triggers a chain of immunological reactions and ultimately leads to the destruction of the cancer cells. Such immunotherapeutic antibodies [...]
Scientists from Yale University have found a way to cause an effective immune response to “complex” cancer tumors using Lupus -related antibodies....
Scientists from Yale University have found a way to cause an effective immune response to “complex” cancer tumors using Lupus -related antibodies....
Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with...
Researchers from Moffitt Cancer Centre have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with...
The management of breast cancer involves various therapeutic approaches. However, many current anticancer treatments indiscriminately damage both...
B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer,...
A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one of the deadliest cancers...
Breast cancer is one of the leading causes of mortality among women worldwide. Tumour necrosis factor α-induced protein 3-interacting protein 1...
Breast cancer is one of the leading causes of mortality among women worldwide. Tumour necrosis factor α-induced protein 3-interacting protein 1...
Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a transformative force in cancer treatment, particularly within the realm of cell...